🇺🇸 Desonide Cream in United States
61 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 23 April 2025 – 23 April 2026
- Total reports: 61
Most-reported reactions
- Rash — 12 reports (19.67%)
- Drug Ineffective — 9 reports (14.75%)
- Pruritus — 9 reports (14.75%)
- Erythema — 7 reports (11.48%)
- Application Site Pain — 4 reports (6.56%)
- Diarrhoea — 4 reports (6.56%)
- Dizziness — 4 reports (6.56%)
- Drug Effective For Unapproved Indication — 4 reports (6.56%)
- Dry Skin — 4 reports (6.56%)
- Fatigue — 4 reports (6.56%)
Other Dermatology approved in United States
Frequently asked questions
Is Desonide Cream approved in United States?
Desonide Cream does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Desonide Cream in United States?
NeoStrata Company, Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.